EUVIMEDEUVIMED entdecken
Crossref

Real-world outcomes of lobectomy, segmentectomy and wedge resection for the treatment of stage c-IA lung carcinoma

Pascal Alexandre Thomas iD, Agathe Seguin-Givelet iD, Pierre-Benoît Pages, Marco Alifano iD, Laurent Brouchet, Pierre-Emmanuel Falcoz, Jean-Marc Baste iD, Matthieu Glorion iD, Yaniss Belaroussi, Marc Filaire, Maxime Heyndrickx, Anderson Loundou iD und 4 weitere

European Journal of Cardio-Thoracic Surgery · 01.07.2024 · 66 (1)

DOI: 10.1093/ejcts/ezae251 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 25.06.2024. Verfasst von Pascal Alexandre Thomas und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Diseases of the Esophagus & Lung Transplantation, Hôpital Nord & CRCM, Inserm UMR 1068, CNRS, UMR 7258, Assistance Pu…. Hauptthemen laut MEDLINE: Lung Neoplasms, Pneumonectomy, Neoplasm Staging. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: French Society of Thoracic and Cardio-Vascular Surgery.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES To determine safety and survival outcomes associated with lobectomy, segmentectomy and wedge resection for early-stage lung cancer by quiring the French population-based registry EPIdemiology in THORacic surgery (EPITHOR). METHODS Retrospective analysis of 19 452 patients with stage c IA lung carcinoma who underwent lobectomy, segmentectomy or wedge resection between 2016 and 2022 with curative-intent. Main outcome measures were 90-day mortality and 5-year overall survival estimates. Proportional hazards regression and propensity score matching were used to adjust outcomes for key patient, tumour and practice environment factors. RESULTS The treatment distribution was 72.2% for lobectomy, 21.5% for segmentectomy and 6.3% for wedge. Unadjusted 90-day mortality rates were 1.6%, 1.2% and 1.1%, respectively (P = 0.10). Unadjusted 5-year overall survival estimates were 80%, 78% and 70%, with significant inter-group survival curves differences (P < 0.0001). Multivariable proportional hazards regression showed that wedge was associated with worse overall survival [adjusted hazard ratio (AHR), 1.23 (95% confidence interval 1.03–1.47); P = 0.021] compared with lobectomy, while no significant difference was disclosed when comparing segmentectomy to lobectomy (1.08 [0.97–1.20]; P = 0.162). The three-way propensity score analyses confirmed similar 90-day mortality rate for wedge resection and segmentectomy compared with lobectomy (hazard ratio: 0.43; 95% confidence interval 0.16–1.11; P = 0.081 and 0.99; 0.48–2.10; P = 0.998, respectively), but poorer overall survival (1.45; 1.13–1.86; P = 0.003 and 1.31; 1–1.71; P = 0.048, respectively). CONCLUSIONS Wedge resection was associated with comparable 90-day mortality but lower overall survival when compared to lobectomy. Overall, all types of sublobar resections may not offer equivalent oncologic effectiveness in real-world settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsPneumonectomyNeoplasm StagingHumansMaleFemaleRetrospective StudiesAgedMiddle AgedTreatment OutcomePropensity ScoreCarcinoma, Non-Small-Cell Lung

Stichwörter der Autor:innen

Lung carcinomaLymphadenectomyStage cIASublobar resection

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Diseases of the Esophagus & Lung Transplantation, Hôpital Nord & CRCM, Inserm UMR 1068, CNRS, UMR 7258, Assistance Publique-Hôpitaux de Marseille & Aix-Marseille University, Marseille, Fr…
  • Department of Thoracic Surgery, Institut Mutualiste Montsouris, Thorax Institute-Curie-Montsouris, Paris, France.
  • Department of Thoracic and Cardiovascular Surgery, Hôpital François Mitterrand, CHU Dijon Bourgogne, Dijon, France.
  • Thoracic Surgery Department, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris & University of Paris Cité, Paris, France.
  • Department of Thoracic Surgery, Hôpital Larrey, Toulouse University Hospitals, Toulouse, France.
  • Department of Thoracic Surgery, Nouvel Hôpital Civil, Strasbourg University Hospitals, Strasbourg, France.

ORCID-Profile: Pascal Alexandre Thomas, Agathe Seguin-Givelet, Marco Alifano, Jean-Marc Baste, Matthieu Glorion, Anderson Loundou, Alex Fourdrain

Förderung

  • French Society of Thoracic and Cardio-Vascular Surgery

Zitieren

APA

Thomas, P. A., Seguin-Givelet, A., Pages, P. B., Alifano, M., Brouchet, L., Falcoz, P. E., Baste, J. M., Glorion, M., Belaroussi, Y., Filaire, M., Heyndrickx, M., Loundou, A., Fourdrain, A., Dahan, M., Boyer, L., & EPITHOR working group (2024). Real-world outcomes of lobectomy, segmentectomy and wedge resection for the treatment of stage c-IA lung carcinoma. European Journal of Cardio-Thoracic Surgery, 66(1). https://doi.org/10.1093/ejcts/ezae251

Vancouver

Thomas PA, Seguin-Givelet A, Pages PB, Alifano M, Brouchet L, Falcoz PE, et al. Real-world outcomes of lobectomy, segmentectomy and wedge resection for the treatment of stage c-IA lung carcinoma. European Journal of Cardio-Thoracic Surgery. 2024;66(1). doi:10.1093/ejcts/ezae251

BibTeX
@article{Thomas2024,
  author = {Thomas, Pascal Alexandre and Seguin-Givelet, Agathe and Pages, Pierre-Benoît and Alifano, Marco and Brouchet, Laurent and Falcoz, Pierre-Emmanuel and Baste, Jean-Marc and Glorion, Matthieu and Belaroussi, Yaniss and Filaire, Marc and Heyndrickx, Maxime and Loundou, Anderson and Fourdrain, Alex and Dahan, Marcel and Boyer, Laurent and EPITHOR working group, EPITHOR working group},
  title = {Real-world outcomes of lobectomy, segmentectomy and wedge resection for the treatment of stage c-IA lung carcinoma},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2024},
  volume = {66},
  number = {1},
  doi = {10.1093/ejcts/ezae251}
}
Kostenlos starten →